AI Powered Pathology Proscia's Fifth Generation Concentriq brings cutting edge AI into digital pathology workflows, helping pathologists and researchers move faster and with greater accuracy. This creates opportunities to sell to pharmaceutical companies, CROs, and large pathology networks aiming to scale AI enabled discovery and diagnosis.

Global Regulatory Edge The platform is FDA cleared and CE IVDR certified, supporting cross border deployments and multi region sales. This strengthens the case to target European and US labs and hospitals seeking regulatory compliant digital pathology solutions and international expansion.

Enterprise Lab Upsell With a global network handling millions of diagnoses and a roster of major pharma and lab customers, Proscia is positioned to upsell enterprise analytics, workflow automation, and IT integrations to large labs and networks seeking scalable solutions.

Strategic Partnerships Active collaborations with AI players and lab groups expand reach and capability; opportunities exist to co sell and jointly pursue labs and pharmacology partners across regions, leveraging integrated AI driven workflows.

Credibility Advantage Recognized for leadership in digital pathology and award wins, Proscia offers strong credibility in procurement discussions, RFPs, and competitive bidding, differentiating from other vendors and easing decision making for potential customers.